Euroclear Announces Wave Two Migration Delay for T2S

Euroclear Belgian, Dutch and French CSD’s require more time to ensure stable migration to securities settlement platform.

shutterstock-136930073
Pan-European securities settlement platform Target2-Securities launched in June this year with the final migration wave scheduled for February 2017.

Following the launch of the European Central Bank (ECB)-pioneered T2S platform in June, Euroclear ESES was due to be part of the second migration wave scheduled for March next year, alongside central securities depositories (CSD) from Belgium (National Bank of Belgium Securities Settlement System) and Portugal (Interbolsa - Sociedade Gestora de Sistemas de Liquidação e de Sistemas Centralizados de Valores Mobiliários, S.A).

However, due to challenges in migrating to the platform, Euroclear has announced its CSDs in Belgium, France and the Netherlands will not meet the March deadline, requiring more time to "ensure a safe and stable migration."

In a statement, Euroclear said it was "full committed to the T2S project" and was continuing to "evaluate possible alternative migration scenarios, in order to minimise the impact of this delay."

Italian CSD Monte Titoli also joined the T2S platform later than planned after encountering similar migration challenges.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Systematic tools gain favor in fixed income

Automation is enabling systematic strategies in fixed income that were previously reserved for equities trading. The tech gap between the two may be closing, but differences remain.

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here